Metabolic heterogeneity underlies reciprocal fates of TH17 cell stemness and plasticity
Peer W. F. Karmaus(St. Jude Children's Research Hospital), Hongbo Chi(St. Jude Children's Research Hospital), Geoffrey Neale(St. Jude Children's Research Hospital), Celeste Rosencrance(Northwestern University), John Easton(St. Jude Children's Research Hospital), Yiping Fan(St. Jude Children's Research Hospital), Kai Yang(Tianjin University of Traditional Chinese Medicine), Seon Ah Lim(Ewha Womans University), Wenan Chen(St. Jude Children's Research Hospital), Andrés A. Herrada(University of Concepción), Yogesh Dhungana(St. Jude Children's Research Hospital), Sherri L. Rankin(St. Jude Children's Research Hospital), Beisi Xu(St. Jude Children's Research Hospital), Yong Cheng(St. Jude Children's Research Hospital), Peter Vogel(Lexicon Pharmaceuticals (United States)), Xiang Chen(Microsoft (United States)), Thanh-Long M. Nguyen(St. Jude Children's Research Hospital)
Cited by 229
Related Papers
HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells
|The Journal of Experimental Medicine|2011|1.8k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Germline Mutations in Predisposition Genes in Pediatric Cancer
|New England Journal of Medicine|2015|1.4k
Regulation and function of mTOR signalling in T cell fate decisions
|Nature reviews. Immunology|2012|996